1. Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration. Issue 1 (31st March 2021) Authors: Le Tilly, Olivier; Azzopardi, Nicolas; Bonneau, Claire; Desvignes, Céline; Oberkampf, Florence; Ezzalfani, Monia; Ternant, David; Turbiez, Isabelle; Gutierrez, Maya; Paintaud, Gilles Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 1(2021) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis. (May 2018) Authors: Bonneau, Claire; Paintaud, Gilles; Trédan, Olivier; Dubot, Coraline; Desvignes, Céline; Dieras, Véronique; Taillibert, Sophie; Tresca, Patricia; Turbiez, Isabelle; Li, Jacques; Passot, Christophe; Mefti, Fawzia; Mouret-Fourme, Emmanuelle; Le Rhun, Emilie; Gutierrez, Maya Journal: European journal of cancer Issue: Volume 95(2018) Page Start: 75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis. Issue 2 (22nd July 2022) Authors: Oberkampf, Florence; Gutierrez, Maya; Trabelsi Grati, Olfa; Rhun, Émilie Le; Trédan, Olivier; Turbiez, Isabelle; Kadi, Amir; Dubot, Coraline; Taillibert, Sophie; Vacher, Sophie; Bonneau, Claire Journal: Neuro-oncology Issue: Volume 25:Issue 2(2023) Page Start: 365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗